| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |